Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship

 - Advance to first-line RAS-mutated mCRC follows the strong signal from new clinical and preclinical data, and agreement with FDA -
 - First-line mCRC represents substantial increase in patient...

Related Keywords

Kiki Patel ,Mark Erlander ,James Levine ,Adam Schayowitz ,Fairooz Kabbinavar ,Richa Kumari ,Nasdaq ,Medicine Team Group Lead For Breast Cancer ,Gilmartin Group ,Taft Communications ,Prnewswire Cardiff Oncology Inc ,Cardiff Oncology Inc ,Exchange Commission ,Pfizer ,Pfizer Inc ,Pfizer Global Product Development ,Pfizer Ignite ,Cardiff Oncology ,Chief Executive Officer ,Vice President ,Medicine Team Group Lead ,Breast Cancer ,Colorectal Cancer ,Scientific Advisory Board ,Chief Medical Officer ,Private Securities Litigation Reform Act ,Oncology Contact ,Markets ,